Incidence of chromosomal aberrations in patients under combined tuberculostatic chemotherapy
- PMID: 6840764
- DOI: 10.1007/BF00291544
Incidence of chromosomal aberrations in patients under combined tuberculostatic chemotherapy
Abstract
Chromosome studies were carried out on the peripheral blood lymphocytes of ten tuberculosis (tb) patients receiving combined tuberculostatic chemotherapy for long intervals (3-10 months) and on those of two control groups, one of ten healthy subjects and the second of ten other tb patients in whom the tuberculostatic treatment had been discontinued 10-19 months previously. An increased proportion of aberrations, particularly chromosomal breaks and achromatic gaps, were observed in the patients under treatment, suggesting a possible synergic interaction of INH and RMA in the production of chromosomal damage.
Similar articles
-
Cytogenetic study of tuberculosis patients before and after tuberculostatic drug treatment.Mutat Res. 1995 Apr;334(2):175-83. doi: 10.1016/0165-1161(95)90009-8. Mutat Res. 1995. PMID: 7885370
-
[The adverse effects of 2 therapy combinations (SM, PAS, INH, RMP, INH, EMB) in the intensive treatment phase of pulmonary tuberculosis].Med Welt. 1976 Feb 20;27(8):389-90. Med Welt. 1976. PMID: 1256308 German. No abstract available.
-
[Side effects of various combinations of rifampin and isoniazid with ethambutol or streptomycin and pyrazinamide in short-term chemotherapy of newly-detected pulmonary tuberculosis].Pneumonol Pol. 1980 Jul;48(7):469-79. Pneumonol Pol. 1980. PMID: 7433146 Polish. No abstract available.
-
The impact of chemotherapy on the care of patients with tuberculosis.Am Rev Respir Dis. 1974 Jun;109(6):636-64. doi: 10.1164/arrd.1974.109.6.636. Am Rev Respir Dis. 1974. PMID: 4209115 Review. No abstract available.
-
Aging and tuberculosis.Gerontology. 1984;30(5):308-15. doi: 10.1159/000212650. Gerontology. 1984. PMID: 6386610 Review.